FLT3 and acute myeloid leukemia: Internal tandem duplication mutations in the fms-like tyrosine kinase 3 (FLT3) gene have been identified in ∼30% of relapsed/refractory acute myeloid leukemia (R/R AML) patients and have been associated with more aggressive disease and worse survival.1